Posterior reversible encephalopathy syndrome overshadowing COVID-19: An Abstruse scenario or a conspicuous association?

References

1. 1.↵
   1. Fugate JE,
   2. Rabinstein AA.

   Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14: 914-925.

   OpenUrlCrossRefPubMedGoogle Scholar
2. 2.↵
   1. Kishfy L,
   2. Casasola M,
   3. Banankhah P,
   4. Parvez A,
   5. Jan YJ,
   6. Shenoy AM, et al.

   Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. J Neurol Sci 2020; 414: 116943.

   OpenUrlCrossRefPubMedGoogle Scholar
3. 3.↵
   1. Parauda SC,
   2. Gao V,
   3. Gewirtz AN,
   4. Parikh NS,
   5. Merkler AE,
   6. Lantos J, et al.

   Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci 2020; 416: 117019.

   OpenUrlPubMedGoogle Scholar
4. 4.↵
   1. Hu B,
   2. Huang S,
   3. Yin L.

   The cytokine storm and COVID-19. J Med Virol 2020: doi: 10.1002/jmv.26232

   Google Scholar
5. 5.↵
   1. Princiotta cariddi L,
   2. Tabaee damavandi P,
   3. Carimati F, et al.

   Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. J Neurol 2020: 1-4.

   Google Scholar